Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends
Hira Choudhury, Manisha Pandey, Pei Xin Chin, et al.
Drug Delivery and Translational Research (2018) Vol. 8, Iss. 5, pp. 1545-1563
Closed Access | Times Cited: 163

Showing 1-25 of 163 citing articles:

Emerging blood–brain-barrier-crossing nanotechnology for brain cancer theranostics
Wei Tang, Wenpei Fan, Joseph Lau, et al.
Chemical Society Reviews (2019) Vol. 48, Iss. 11, pp. 2967-3014
Closed Access | Times Cited: 506
Improving cellular uptake of therapeutic entities through interaction with components of cell membrane
Renshuai Zhang, Xiaofei Qin, Fan‐Dong Kong, et al.
Drug Delivery (2019) Vol. 26, Iss. 1, pp. 328-342
Open Access | Times Cited: 272
Targeted drug delivery to the brain via intranasal nanoemulsion: Available proof of concept and existing challenges
Bappaditya Chatterjee, Bapi Gorain, Keithanchali Mohananaidu, et al.
International Journal of Pharmaceutics (2019) Vol. 565, pp. 258-268
Open Access | Times Cited: 168
PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution
Zahid Hussain, Shahzeb Khan, Muhammad Ali Imran, et al.
Drug Delivery and Translational Research (2019) Vol. 9, Iss. 3, pp. 721-734
Closed Access | Times Cited: 167
Nanomedicine for brain cancer
Sabina Quader, Kazunori Kataoka, Horacio Cabral
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114115-114115
Open Access | Times Cited: 103
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 99
Recent Advances in the Surface Functionalization of PLGA-Based Nanomedicines
Mazen M. El‐Hammadi, José L. Arias
Nanomaterials (2022) Vol. 12, Iss. 3, pp. 354-354
Open Access | Times Cited: 81
Brain-targeted drug delivery - nanovesicles directed to specific brain cells by brain-targeting ligands
Ricardo Moreira, Clévio Nóbrega, Luís Pereira de Almeida, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 22
Advancing neurological disorders therapies: Organic nanoparticles as a key to blood-brain barrier penetration
Zahra Razavi, Seyed Sina Alizadeh, F. S. Razavi, et al.
International Journal of Pharmaceutics (2025) Vol. 670, pp. 125186-125186
Open Access | Times Cited: 10
Hyaluronic acid-functionalized nanomedicines for CD44-receptors-mediated targeted cancer therapy: A review of selective targetability and biodistribution to tumor microenvironment
Alaa Raad Al Jayoush, Mohamed Haider, Saeed Ahmad Khan, et al.
International Journal of Biological Macromolecules (2025), pp. 142486-142486
Closed Access | Times Cited: 2
Serum protein-based nanoparticles for cancer diagnosis and treatment
Haroon Iqbal, Tao Yang, Ting Li, et al.
Journal of Controlled Release (2020) Vol. 329, pp. 997-1022
Closed Access | Times Cited: 130
Synthesis and functionalization of hyperbranched polymers for targeted drug delivery
Alireza Kavand, Nicolas Anton, Thierry Vandamme, et al.
Journal of Controlled Release (2020) Vol. 321, pp. 285-311
Open Access | Times Cited: 116
Blood-brain barrier receptors and transporters: an insight on their function and how to exploit them through nanotechnology
Rui Pedro Moura, Cláudia Martins, Soraia Pinto, et al.
Expert Opinion on Drug Delivery (2019) Vol. 16, Iss. 3, pp. 271-285
Closed Access | Times Cited: 108
Recent advances in nanoparticles mediated photothermal therapy induced tumor regression
A. KUMAR, Sunil Kumar Dubey, Sanjay Tiwari, et al.
International Journal of Pharmaceutics (2021) Vol. 606, pp. 120848-120848
Closed Access | Times Cited: 99
Cell membrane cloaked nanomedicines for bio-imaging and immunotherapy of cancer: Improved pharmacokinetics, cell internalization and anticancer efficacy
Zahid Hussain, Muhammad Abdur Rahim, Nasrullah Jan, et al.
Journal of Controlled Release (2021) Vol. 335, pp. 130-157
Closed Access | Times Cited: 97
RGD engineered dendrimer nanotherapeutic as an emerging targeted approach in cancer therapy
Afsana Sheikh, Shadab Md, Prashant Kesharwani
Journal of Controlled Release (2021) Vol. 340, pp. 221-242
Closed Access | Times Cited: 94
Intelligent Nanocomposites with Intrinsic Blood–Brain‐Barrier Crossing Ability Designed for Highly Specific MR Imaging and Sonodynamic Therapy of Glioblastoma
Kaicheng Liang, Zhicong Li, Yu Luo, et al.
Small (2020) Vol. 16, Iss. 8
Closed Access | Times Cited: 92
Modeling Nanocarrier Transport across a 3D In Vitro Human Blood‐Brain–Barrier Microvasculature
Sharon Wei Ling Lee, Marco Campisi, Tatsuya Osaki, et al.
Advanced Healthcare Materials (2020) Vol. 9, Iss. 7
Open Access | Times Cited: 83
<p>Transferrin Receptor-Targeted PEG-PLA Polymeric Micelles for Chemotherapy Against Glioblastoma Multiforme</p>
Ping Sun, Yue Xiao, Qianqian Di, et al.
International Journal of Nanomedicine (2020) Vol. Volume 15, pp. 6673-6687
Open Access | Times Cited: 81
Target delivering paclitaxel by ferritin heavy chain nanocages for glioma treatment
Wei Liu, Qing Lin, Yu Fu, et al.
Journal of Controlled Release (2019) Vol. 323, pp. 191-202
Closed Access | Times Cited: 79
Nano-enabled theranostics for cancer
Palani Sharmiladevi, Koyeli Girigoswami, Viswanathan Haribabu, et al.
Materials Advances (2021) Vol. 2, Iss. 9, pp. 2876-2891
Open Access | Times Cited: 75
Strategies to overcome/penetrate the BBB for systemic nanoparticle delivery to the brain/brain tumor
Haijun Liu, Peisheng Xu
Advanced Drug Delivery Reviews (2022) Vol. 191, pp. 114619-114619
Open Access | Times Cited: 68
Transferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma
Maria João Ramalho, Joana A. Loureiro, Manuel A. N. Coelho, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 279-279
Open Access | Times Cited: 63
Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer
Afsana Sheikh, Shadab Md, Prashant Kesharwani
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112530-112530
Open Access | Times Cited: 62
Recent Progress of RGD Modified Liposomes as Multistage Rocket Against Cancer
Afsana Sheikh, Nabil A. Alhakamy, Shadab Md, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 52
Page 1 - Next Page

Scroll to top